1. Home
  2. NNDM vs PRTC Comparison

NNDM vs PRTC Comparison

Compare NNDM & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.80

Market Cap

361.4M

Sector

Technology

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.91

Market Cap

386.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNDM
PRTC
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.4M
386.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NNDM
PRTC
Price
$1.80
$16.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.8M
5.1K
Earning Date
11-19-2025
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$69,663,000.00
$6,391,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.86
Revenue Growth
26.75
1265.60
52 Week Low
$1.31
$13.30
52 Week High
$2.74
$23.35

Technical Indicators

Market Signals
Indicator
NNDM
PRTC
Relative Strength Index (RSI) 60.24 51.08
Support Level $1.43 $16.01
Resistance Level $1.65 $18.05
Average True Range (ATR) 0.08 0.35
MACD 0.02 0.15
Stochastic Oscillator 88.10 55.37

Price Performance

Historical Comparison
NNDM
PRTC

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: